In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges

被引：180

作者：

Mout, Rubul ^{[1
]}

Ray, Moumita ^{[1
]}

Lee, Yi-Wei ^{[1
]}

Scaletti, Federica ^{[1
]}

Rotello, Vincent M. ^{[1
]}

机构：

[1] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA

来源：

BIOCONJUGATE CHEMISTRY | 2017年 / 28卷 / 04期

关键词：

MUSCULAR-DYSTROPHY; MEDIATED DELIVERY; MOUSE MODEL; HUMAN-CELLS; GENOME; CAS9; RNA; CRISPR-CAS9; NUCLEASES; ENDONUCLEASE;

D O I：

10.1021/acs.bioconjchem.7b00057

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The successful use of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based gene editing for therapeutics requires efficient in vivo delivery of the CRISPR components. There are, however, major challenges on the delivery front. In this Topical Review, we will highlight recent developments in CRISPR delivery, and we will present hurdles that still need to be overcome to achieve effective in vivo editing.

引用

页码：880 / 884

页数：5

共 39 条

[1] In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa [J].

Bakondi, Benjamin ;

Lv, Wenjian ;

Lui, Bin ;

Jones, Melissa K. ;

Tsai, Yuchun ;

Kim, Kevin J. ;

Levy, Rachelle ;

Akhtar, Aslam Abbasi ;

Breunig, Joshua J. ;

Svendseni, Clive N. ;

Wang, Shaomei .

MOLECULAR THERAPY, 2016, 24 (03) :556-563

[2] Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9 [J].

Cheng, Ranran ;

Peng, Jin ;

Yan, Yonghong ;

Cao, Peili ;

Wang, Jiewei ;

Qiu, Chen ;

Tang, Lichun ;

Liu, Di ;

Tang, Li ;

Jin, Jianping ;

Huang, Xingxu ;

He, Fuchu ;

Zhang, Pumin .

FEBS LETTERS, 2014, 588 (21) :3954-3958

[3] A multifunctional AAV-CRISPR-Cas9 and its host response [J].

Chew, Wei Leong ;

Tabebordbar, Mohammadsharif ;

Cheng, Jason K. W. ;

Mali, Prashant ;

Wu, Elizabeth Y. ;

Ng, Alex H. M. ;

Zhu, Kexian ;

Wagers, Amy J. ;

Church, George M. .

NATURE METHODS, 2016, 13 (10) :868-+

[4] Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases [J].

Cho, Seung Woo ;

Kim, Sojung ;

Kim, Yongsub ;

Kweon, Jiyeon ;

Kim, Heon Seok ;

Bae, Sangsu ;

Kim, Jin-Soo .

GENOME RESEARCH, 2014, 24 (01) :132-141

[5] Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].

Cho, Seung Woo ;

Kim, Sojung ;

Kim, Jong Min ;

Kim, Jin-Soo .

NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232

[6] Multiplex Genome Engineering Using CRISPR/Cas Systems [J].

Cong, Le ;

Ran, F. Ann ;

Cox, David ;

Lin, Shuailiang ;

Barretto, Robert ;

Habib, Naomi ;

Hsu, Patrick D. ;

Wu, Xuebing ;

Jiang, Wenyan ;

Marraffini, Luciano A. ;

Zhang, Feng .

SCIENCE, 2013, 339 (6121) :819-823

[7] Therapeutic genome editing: prospects and challenges [J].

Cox, David Benjamin Turitz ;

Platt, Randall Jeffrey ;

Zhang, Feng .

NATURE MEDICINE, 2015, 21 (02) :121-131

[8] Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing [J].

Ding, Qiurong ;

Strong, Alanna ;

Patel, Kevin M. ;

Ng, Sze-Ling ;

Gosis, Bridget S. ;

Regan, Stephanie N. ;

Cowan, Chad A. ;

Rader, Daniel J. ;

Musunuru, Kiran .

CIRCULATION RESEARCH, 2014, 115 (05) :488-+

[9] Characterization of Genome Integrity for Oversized Recombinant AAV Vector [J].

Dong, Biao ;

Nakai, Hiroyuki ;

Xiao, Weidong .

MOLECULAR THERAPY, 2010, 18 (01) :87-92

[10] The new frontier of genome engineering with CRISPR-Cas9 [J].

Doudna, Jennifer A. ;

Charpentier, Emmanuelle .

SCIENCE, 2014, 346 (6213) :1077-+

← 1 2 3 4 →